Long-term follow up after switching from original infliximab to an infliximab biosimilar: real-world data.
Guerra Veloz MF, Belvis Jiménez M, Valdes Delgado T, Castro Laria L, Maldonado Pérez B, Perea Amarillo R, Merino Bohórquez V, Caunedo Álvarez Á, Vilches Arenas Á, Argüelles-Arias F.
Guerra Veloz MF, et al.
Therap Adv Gastroenterol. 2019 Jun 18;12:1756284819858052. doi: 10.1177/1756284819858052. eCollection 2019.
Therap Adv Gastroenterol. 2019.
PMID: 31258621
Free PMC article.